Once-Weekly Semaglutide in Adults with Overweight or Obesity.
1,457
mentions
- News 971
- X 347
- Blogs 74
- YouTube 37
- +3 more
Julio Rosenstock
PubHawk tracks social media discussions for 8 articles by authors named Julio Rosenstock.
Mentions
4,961
Peak: 136 in Aug 2025
across 8 tracked articles
Extended reach
23,952,330
potential audience
Total likes
66,555
Video views
3,616,161
Mentions per month
Sep 2014 – Dec 2025Where it's discussed
-
News2,596 articles
-
X / Twitter1,948 posts
-
Blogs176 articles
-
Facebook95 posts
-
YouTube83 videos
-
Reddit30 posts
-
Bluesky18 posts
-
Instagram13 posts
-
LinkedIn2 posts
Tracked by PubHawk
Most discussed articles
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
1,123
mentions
- News 777
- X 288
- Blogs 33
- YouTube 19
- +2 more
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
444
mentions
- X 239
- News 141
- Facebook 29
- Blogs 21
- +3 more
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.
427
mentions
- X 206
- News 194
- Blogs 14
- Facebook 6
- +2 more
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.
424
mentions
- X 237
- News 162
- Blogs 12
- Facebook 10
- +1 more
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial.
416
mentions
- News 228
- X 164
- Blogs 14
- YouTube 5
- +2 more
Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity.
363
mentions
- X 263
- News 37
- Facebook 26
- Reddit 15
- +5 more
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes.
307
mentions
- X 204
- News 86
- Bluesky 10
- Blogs 5
- +1 more
From PubMed
All publications
Searching PubMed…